Here, we investigated how Plexin-B2 enables GBM cells to gain invasiveness by utilizing a set of patient-derived GBM stem cell (GSC) lines, which preserve major pathophysiology of parental GBM, including infiltrative invasion in vivo24–27. Here, PLXNB2 is linked to glioblastoma.